FDA Considering Drug/Companion IVD Review Policy | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – The US Food and Drug Administration expects that companies developing drugs or in vitro companion diagnostic tests that depend on each other will file applications for the drug and the test concurrently, according to a guidance document FDA is still developing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.